Clinical Trial Update: Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

Pfizer completed a Phase 3 trial evaluating PF-04965842, with or without topical medications, for moderate to severe atopic dermatitis in patients aged 12 and o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• PF-04965842

Snippet

Sponsor: Pfizer | Conditions: Dermatitis, Atopic | Phase 3 | Status: COMPLETED